- Forum will be held on May 30
at the Science Museum, London
- Chaired by Professor Sir Munir
Pirmohamed, Forum to consist of four panel sessions
highlighting solutions to pressing issues facing private and
public-sector innovators in the healthcare space
- Keynote presentation by Dr Miles
Congreve, Chief Scientific Officer, Isomorphic Labs, and
closing remarks from Dr Hilary
Marston, Chief Medical Officer, Food and Drug
Administration
- Awards Ceremony to be hosted following Forum at the Natural
History Museum, London
LONDON, May 2, 2024 /PRNewswire/ -- The Galien Foundation
will celebrate the third annual Prix Galien UK Forum at the Science
Museum in London, on May 30, 2024, from 9:30
AM – 5:00 PM. The Prix Galien
UK Forum brings together industry scientists, researchers, and
organisations at the forefront of scientific advancement to
exchange and offer perspectives on the future of global health.
Together with the evening Prix Galien Awards Ceremony recognising
the best in UK medicine, the events reflect the worldwide mission
of The Galien Foundation to improve the human condition through
breakthrough innovations that progress the understanding in
diagnosing, treating, and curing disease.
"The Prix Galien UK Forum is an exemplary platform for
scientific discussion and dynamic peer-led conversations on the
most prevalent topics and challenges we face as professionals in
the life sciences arena," commented Professor Sir Munir Pirmohamed, David Weatherall Chair of
Medicine at the University of Liverpool
and the NHS Chair of Pharmacogenetics, Chair of the Prix Galien UK
Committee. "The Forum is an unmissable opportunity to delve into
the leading minds working across a myriad of health-related
research and product development areas."
This year's lineup will feature the following panels:
9:40 AM – 10:40 AM
PANEL 1: No decision for me
without me: Putting patients at the heart of drug
development
CHAIR
Dr Mel Walker, Life Sciences
Strategic Advisor and Managing Director, BioPharma Futures
PANELISTS
Robyn Bent, Director of CDER's
Patient-Focused Drug Development (PFDD) Program, FDA
Dr Sarah Gheuens, Chief Medical
Officer, Head of R&D, Agios Pharmaceuticals
Dr Maria Mavris, Patient Liaison at
European Medicines Agency
Elizabeth Vroom, Co-founder and
chair of the World Duchenne Organization
11:00 AM – 12:00 PM
PANEL 2: Introducing New
Technologies: Optimising pathways to improve population
health
CHAIR
Dame June Raine, Chief Executive,
Medicines and Healthcare products Regulatory Agency
PANELISTS
Pr Gary Ford, Chief Executive
Officer, Health Innovation Oxford and Thames Valley
Hilary Hutton-Squire, Vice
President, Head of Global Value and Access, Gilead Sciences
Sir Harpal Kumar, President,
BioPharma Business & Europe,
GRAIL, LLC
Dr Hakim Yadi, CEO, Closed Loop
Medicine
12:45 PM – 1:30 PM
KEYNOTE
ADDRESS: Can we use artificial intelligence to design
new drugs?
Dr Miles
Congreve, Chief Scientific Officer, Isomorphic Labs
1:30 – 2:30 PM
PANEL
3: Innovation in R&D: The birth of
breakthroughs
CHAIR
Lord Prior of Brampton, Deputy Chairman UK and Global Senior
Advisor at Lazard, Chairman of Protas; Chairman of the Cambridge
Life Sciences Council and Chairman of Tympa Health
PANELISTS
Tamsin Berry, Co-founder and partner
of Population Health Partners
Dr Joep Muijrers, General Partner,
Gilde Healthcare
Dr Matthias Müllenbeck, SVP, Head
Global Business Development & Alliance Management
Dr Jane Osbourn, CSO at Alchemab
Therapeutics Ltd
2:45 – 3:55 PM
PANEL
4: Data Driven Medicine: The NHS as a strategic partner in life
science
CHAIR
Dr Vin Diwakar, National Director
for Transformation (interim), NHS England
PANELISTS
Dr Michelle Longmire, CEO &
Co-Founder, Medable
Pr Andrew Morris, Director, Health
Data Research UK & Professor of Medicine and Vice Principal
Data Science, University of
Edinburgh
Dr Adrian Rabe, Head of RWE Centre
of Excellence, Boehringer Ingelheim Ltd.
Richard Stephens, Patient partner;
Chair of use MY data, UK Cancer Research Advocates Forum
Ming Tang, Chief Data and Analytics
Officer, NHS England
3:55 – 4:40 PM
CLOSING SPEECH
Dr Hilary
Marston, Chief Medical Officer, Food and Drug
Administration
Bruno Cohen, Chairman of the
Galien Foundation, commented, "It is wonderful to welcome both
returning and new industry thought leaders to the Prix Galien UK
Forum stage. As the Forum enters its third year, the quality and
breadth of our panel discussions continue to pave the way for a
stronger, healthier, and sustainable future for global
healthcare."
Following the Prix Galien UK Forum, the Prix Galien UK Awards
Ceremony will take place at the Natural History Museum,
London, from 7:30 PM – 10:30 PM.
Under the leadership of Professor Sir Munir
Pirmohamed, the Prix Galien UK Awards Committee will select
the latest cohort of leading innovators and products in the life
sciences industries to be awarded for their profound
achievements.
To learn more about the 2024 Prix Galien Forum and Awards
Ceremony, please visit: https://prixgalien.co.uk/.
To purchase a ticket to the events, please
visit: https://join.galienfoundation.org/
About the Galien Foundation
The Galien Foundation
fosters, recognises and rewards excellence in scientific innovation
to improve the state of human health. Our vision is to be the
catalyst for the development of the next generation of innovative
treatments and technologies that will impact the state of medical
practice and save lives.
The Foundation oversees and directs activities in the UK for the
Prix Galien, an international awards programme dedicated to
progress through innovative medicines development, with chapters in
14 countries, Africa and an
inaugural chapter established in India in 2024. The Prix Galien was created in
1970 by Roland Mehl in honour of
Galien, the father of medical science and modern pharmacology.
Worldwide, the Prix Galien is regarded as the equivalent of the
Nobel Prize in biopharmaceutical research.
For more information, visit www.galienfoundation.org.
Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/
Media Contact (UK):
Julian Tyndale-Biscoe
Finn Partners
Julian.Tyndale-biscoe@finnpartners.com
+44 20 3217 7060
Media Contact (Global):
Kara
Bradley
Finn Partners
Kara.Bradley@finnpartners.com
+1 646-213-7243
Logo -
https://mma.prnewswire.com/media/564722/The_Galien_Foundation_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/the-galien-foundations-prix-galien-uk-forum-returns-to-london-in-may-2024-302133869.html